October 2015 Respiratory Disease Articles from Consultant 360  

Smoking Cessation Drug 46% Effective in Women
A new study looks at the effectiveness of varenicline at 3, 6, and 12 months after the start of smoking cessation treatment.

http://www.consultant360.com/exclusives/smoking-cessation-drug-46-effective-women

USPSTF Questions Efficacy of E-Cigarette Use For Smoking Cessation
The US Preventive Services Task Force has updated their 2009 guidelines on smoking cessation interventions and further examined the effectiveness of electronic nicotine delivery systems.

http://www.consultant360.com/exclusives/uspstf-questions-efficacy-e-cigarette-use-smoking-cessation

Study: Smoking Cessation Drug Not Linked to Heart Attack, Depression
A recent study examined the validity of previous reports on the dangers of depression, suicide, and heart attack associated with the use ofvarenicline, a highly-effective smoking cessation drug.

http://www.consultant360.com/exclusives/study-smoking-cessation-drug-not-linked-heart-attack-depression

Are LTRAs an Effective Option for Asthma Monotherapy?
A new systematic review and meta-analysis investigated whether leukotriene-receptor antagonists were effective as monotherapy for asthma control.

http://www.consultant360.com/exclusives/are-ltras-effective-option-asthma-monotherapy

FDA Approves New Indication for COPD Drug

The FDA has approved a drug already indicated for COPD treatment for the long-term, once-daily maintenance of asthma in individuals 12 years old and older.

http://www.consultant360.com/exclusives/fda-approves-new-indication-copd-drug